<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03856346</url>
  </required_header>
  <id_info>
    <org_study_id>Phaco-vity-biometry study</org_study_id>
    <nct_id>NCT03856346</nct_id>
  </id_info>
  <brief_title>Intraocular Lens Power Calculation for Combined Phaco-vitrectomy Procedures</brief_title>
  <official_title>Intraocular Lens Power Calculation for Combined Phaco-vitrectomy Procedures: Calculation of a New Constant for Biometry IOL-formulas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cantonal Hospital of St. Gallen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cantonal Hospital of St. Gallen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the degree of refractive error postoperatively in
      combined procedures and to calculate a new constant in order to improve current state of the
      art biometry calculations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The IOL power calculation in combined phaco-vitrectomy has been performed similar to that in
      cataract surgery alone. In patients who undergo combined phaco-vitrectomy, deviations in
      refractive outcomes may be observed because of possible errors in measurement of axial
      length, changes in the properties of the vitreous cavity after removal of the vitreous, or
      intraocular tamponade. Most of the previous studies have reported variable degrees of myopic
      shift after phaco-vitrectomy for diabetic retinopathy, epiretinal membrane, and macular hole.
      Furthermore, use of intraoperative gas may increase further the risk of anterior displacement
      of the intraocular lens which may induce a higher myopic shift. However, these publications
      did not provide any quantification of the spherical deviations nor calculate any specific
      constant in order to improve currents state of art biometry calculations.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Refractive prediction error (measured by subjective refraction, in diopters)</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>postoperative actual subjective refraction minus preoperative planned refraction in spherical equivalence (in diopters)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Absolute prediction error (measured by subjective refraction, in diopters)</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>absolute value of the difference between postoperative actual refraction and preoperative planned refraction (in diopters)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Axial Length (measured by biometry, in milimeters)</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>Change of axial length postoperatively (in milimeter)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in corneal curvature (measured by corneal topography, in diopters)</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>change in corneal curvature (in diopters)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Intraocular Lens Calculation</condition>
  <condition>Combined Phaco-vitrectomy</condition>
  <arm_group>
    <arm_group_label>Phaco-vitrectomy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Biometry</intervention_name>
    <description>Biometry for phaco-vitrectomy procedures pre- and postoperatively</description>
    <arm_group_label>Phaco-vitrectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who undergo a combined procedure with phacoemulsification and pars plana
        vitrectomy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who undergo a combined procedure with phacoemulsification and pars plana
             vitrectomy

        Exclusion Criteria:

          -  Sulcus fixation of the IOL, sulcus suture of the IOL, or intra-scleral IOL fixation
             because of intraoperative posterior capsule rupture

          -  corneal disease, such as keratoconus, that interfered with refractive results

          -  IOL implantation with a toric IOL or multifocal IOL

          -  History of previous vitrectomy or corneal transplantation

          -  Other coexisting ocular disease such as proliferative diabetic retinopathy, advanced
             age-related macular degeneration, uveitis, acute retinal necrosis, Coat's disease,
             proliferative vitreous retinopathy, or trauma

          -  Intraocular tamponade using silicon oil
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Josef Guber, MD</last_name>
    <phone>+41 71 494 17 54</phone>
    <email>josef.guber@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cantonal Hospital of Sankt Gallen</name>
      <address>
        <city>Sankt Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>February 5, 2019</study_first_submitted>
  <study_first_submitted_qc>February 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2019</study_first_posted>
  <last_update_submitted>April 30, 2019</last_update_submitted>
  <last_update_submitted_qc>April 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cantonal Hospital of St. Gallen</investigator_affiliation>
    <investigator_full_name>Josef Guber</investigator_full_name>
    <investigator_title>Consultant ophthalmic surgeon</investigator_title>
  </responsible_party>
  <keyword>Vitrectomy</keyword>
  <keyword>Phacoemulsification</keyword>
  <keyword>Biometry</keyword>
  <keyword>IOL calculation</keyword>
  <keyword>Cataract</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

